Affimed (AFMD) Stock Rockets On Data
Affimed NV (NASDAQ: AFMD) is running for the top in the market this morning, and for good reason. The company announced positive initial clinical data surrounding AFM13, a drug under development for the treatment of cancer. Here’s the scoop: Affimed Announces Positive Clinical Data In the press release, Affimed announced positive initial data from a … Read more